These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21775763)

  • 1. Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.
    Basu G; Mohapatra A; Manipadam MT; Mani SE; John GT
    Nephrol Dial Transplant; 2011 Oct; 26(10):3412-5. PubMed ID: 21775763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.
    Di Paolo S; Teutonico A; Ranieri E; Gesualdo L; Schena PF
    Am J Kidney Dis; 2007 Mar; 49(3):462-70. PubMed ID: 17336708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
    Campistol JM; Schena FP
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.
    Marco de F; Infante B; Giovanni S; Gesualdo L
    Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual Kaposi's sarcoma in a renal transplant recipient.
    Costa Ferreira P; Miguel Pereira J; Oliveira I; Pinho C; Cardoso A; Reis J; Amarante J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2830-1. PubMed ID: 16204279
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.
    Gheith O; Bakr A; Wafa E; Fouda A; El Agroudy A; Refaie A; Donia A; Sabry A; Sobh M; Shokeir A; Ghoneim M
    Clin Exp Nephrol; 2007 Sep; 11(3):251-254. PubMed ID: 17891357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient.
    Ho CM; Huang SF; Hu RH; Ho MC; Wu YM; Lee PH
    Clin Transplant; 2010; 24(1):127-32. PubMed ID: 19919613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report.
    Detroyer D; Deraedt K; Schöffski P; Hauben E; Lagrou K; Naesens M; Delforge ML; Kuypers D
    Transpl Infect Dis; 2015 Apr; 17(2):303-7. PubMed ID: 25645490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive therapy and Kaposi's sarcoma: two case reports (author's transl)].
    Guillet G; Chouvet B; Thivolet J; Perrot H
    Ann Dermatol Venereol; 1980; 107(10):907-19. PubMed ID: 7235477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma after renal transplantation.
    Kanitakis J
    N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16120869
    [No Abstract]   [Full Text] [Related]  

  • 16. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
    Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
    Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus for Kaposi's sarcoma.
    Wasywich CA; Croxson MC; van Doornum GJ; Coverdale HA; Ruygrok PN
    J Heart Lung Transplant; 2006 Jun; 25(6):726-9. PubMed ID: 16730579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus in renal transplantation.
    Morath C; Arns W; Schwenger V; Mehrabi A; Fonouni H; Schmidt J; Zeier M
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii61-viii65. PubMed ID: 17890266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of Kaposi's sarcoma in a renal allograft recipient.
    Marsman WA; Van Gelder T; Mulder AH; Ijzermans JN; Zietse R; Weimar W
    Nephrol Dial Transplant; 1995; 10(6):900-1. PubMed ID: 7566628
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.